Institutional investors purchased a net $467.2 thousand shares of TNXP during the quarter ended June 2017 and now own 35.30% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
B. RILEY CAPITAL MANAGEMENT LLC Bought 378.1 Thousand shares of Tonix Pharmaceuticals Hol...
OPALEYE MANAGEMENT, INC. Bought 135.0 Thousand shares of Tonix Pharmaceuticals Hol...